Prognostic factors for overall survival in castration-resistant metastatic prostate cancer treated with docetaxel (MeProCSS): results from a German real-world cohort - Steffens, Felix; Wessels, Frederik; Hetjens, Svetlana; Carl, Nicolas; Nitschke, Katja; Uysal, Daniel; Moharam, Nadim; Patroi, Paul; Worst, Thomas; Kowalewski, Karl-Friedrich; Michel, Maurice Stephan; Neuberger, Manuel (International urology and nephrology, 2025)
Gesehen am 23.07.2025